A 6927 New York Assembly · 2025 Regular Session

Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy

Summary
Provides that prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy maybe include the name of the dispensing practice instead of the prescriber; provides for notice to patients.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 18, 2025 Last action May 28, 2026
Maddy AI version diff · 1 comparison

What changed between versions

A6927 A6927A · 3 edits
MINOR
The bill was amended to remove mifepristone and misoprostol from the list of medications requiring specific prescription label formatting. This change narrows the bill's scope, meaning these specific drugs are no longer subject to the new labeling requirements that allow using the practice name instead of the individual provider's name.
Scope change
The bill's scope was reduced by removing mifepristone and misoprostol from the list of covered medications.
SCOPE

Mifepristone and misoprostol were removed from the list of medications covered by the new prescription label requirements.

REQUIREMENT

The list of medications in the Education Law and Public Health Law was updated to exclude mifepristone and misoprostol.

TECHNICAL

Minor formatting adjustments were made to the bill header and sponsor list to reflect committee actions and additional co-sponsors.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
2
Committee
2
Amendments
2
May 28, 2026
Lower · Passed
PRINT NUMBER 6927A
lower
May 28, 2026
Lower · Passed
AMEND (T) AND RECOMMIT TO HIGHER EDUCATION
lower
Jan 7, 2026
Committee
REFERRED TO HIGHER EDUCATION
lower
Mar 18, 2025
Committee
REFERRED TO HIGHER EDUCATION
lower
1 primary · 20 co-sponsors

Sponsors